Mono Pharmacare Cites SME Listing Exemption for Corporate Governance Filing
Mono Pharmacare Ltd 路 Others (Uncategorized) 路 27 Oct 2026, 11:34 pm
Mono Pharmacare Cites SME Listing Exemption for Corporate Governance Filing Mono Pharmacare Limited confirmed to the National Stock Exchange of India that submission of the Corporate Governance Report under Regulation 27(2) is not applicable for the quarter ended 30th Sep'26. The company invoked exemptions under Regulation 15(2)(b) of Chapter IV of SEBI (LODR) Regulations, 2015, which exempts companies listed on the SME exchange from this filing requirement.
Original exchange filing (PDF)
More announcements from Mono Pharmacare Ltd
- MONOPHARMA : 21-Nov-2026 : The Company has informed the Exchange that a Board meeting to be held on November 14, 2026 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on November 21, 2026, To consider and approve the financial results for the period ended September 30, 2026 路 21 Nov 2026
- Mono Pharmacare Limited has informed the Exchange about Board Meeting to be held on 14-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . 路 14 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 路 14 Nov 2026
- Integrated filing governance for quarter 2 2026-27 路 27 Oct 2026
- Integrated filing governance for quarter 1 2026-27 路 15 Oct 2026
- Mono Pharmacare Limited has informed regarding Submission of the Compliance Report on Corporate Governance for the Q1 FY 2026-27 路 15 Oct 2026
- Mono Pharmacare Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 30, 2026. Further, the company has informed the Exchange regarding voting results. 路 02 Oct 2026
- Mono Pharmacare Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 30, 2026 路 30 Sept 2026
